PRKN and Parkinson disease: Indeed, whilst the patient's initial DaTSCAN was negative, he went on to develop progressive parkinsonism without corresponding changes in brain iron accumulation on interval MRI suggesting clinical progression of the patient's mutated PARK2-associated phenotype, and prompting consideration of a repeat DaTSCAN and Levodopa trial.